Abstract Details

Title Development of Phosphorodiamidate Morpholino Oligomers (PMOs) for the Treatment of Duchenne Muscular Dystrophy (DMD)

Topic Neuromuscular and Clinical Neurophysiology (EMG)

Presentation(s) S42 - (-)

Poster/Presentation
Number 008

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
DE Frank PRESENTER	No disclosure on file
Genevieve A. Laforet, MD, PhD (Genzyme, a Sanofi Company)	No disclosure on file
Celeste Di Johnson	No disclosure on file
	No disclosure on file
Arvind Narayana	Arvind Narayana has received personal compensation for serving as an employee of Akcea Therapeutics. Arvind Narayana has received stock or an ownership interest from Akcea Therapeutics.
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��